Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults
Completed
AIDS Clinical Trials Group
N/A
2003-10-01
HIV replication in resting CD4 cells is so minimal that anti-HIV drugs often fail to destroy
the virus in these cells. Enfuvirtide, also known as T-20, is a type of anti-HIV drug called
a fusion inhibitor. The purpose of this study is to test the ability of a T-20-enhanced
treatment regimen to decrease the number of resting CD4 cells that become infected with HIV.
Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults
Completed
National Institute of Allergy and Infectious Diseases (NIAID)
N/A
2003-10-01
HIV replication in resting CD4 cells is so minimal that anti-HIV drugs often fail to destroy
the virus in these cells. Enfuvirtide, also known as T-20, is a type of anti-HIV drug called
a fusion inhibitor. The purpose of this study is to test the ability of a T-20-enhanced
treatment regimen to decrease the number of resting CD4 cells that become infected with HIV.
Preventing Sexual Transmission of HIV With Anti-HIV Drugs
Completed
HIV Prevention Trials Network
Phase 3
2005-02-01
This study will determine whether anti-HIV drugs can prevent the sexual transmission of HIV
among couples in which one partner is HIV infected and the other is not.
Preventing Sexual Transmission of HIV With Anti-HIV Drugs
Completed
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3
2005-02-01
This study will determine whether anti-HIV drugs can prevent the sexual transmission of HIV
among couples in which one partner is HIV infected and the other is not.
Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia
Withdrawn
Kirby Institute
Phase 2/Phase 3
1969-12-31
Tenofovir disoproxil fumarate (also known as tenofovir DF or Viread) is used with other
anti-HIV drugs to treat HIV infection. Taking tenofovir DF every day may also prevent HIV
infection. This study will determine if taking a tenofovir DF tablet every day is safe and
effective in preventing HIV infection. Participants in the study will be sex workers in Phnom
Penh, Cambodia.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
